Home › Funds › IMC-Chicago, LLC › MRNA

IMC-Chicago, LLC position in MRNA

MODERNA INC · Health Care

IMC-Chicago, LLC reported holding 3,068,600 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$590.9M, representing 0.98% of its reported portfolio and ranking #18 among its reported holdings. IMC-Chicago, LLC has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.07M sh
Reported value held$590.92M
Portfolio Weight0.98%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How IMC-Chicago, LLC's MRNA position evolved

IMC-Chicago, LLC first disclosed a stake in MRNA in Q3 2023 at 652,600 shares (US$67.4M). The position peaked in Q3 2026 at 3,068,600 shares, worth US$590.9M. Across 13 filings, IMC-Chicago, LLC increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,068,600 shares valued at US$590.9M — an increase of 1,366,400 shares quarter over quarter.. Notable position changes include a 89% trim in Q2 2024 (shares fell 44% over the following quarter), a 5634% increase in Q4 2024 (shares fell 32% over the following quarter), a 757% increase in Q1 2026 (shares rose 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 652.60K $67.41M New
Q4 2023 861.70K $85.70M Add
Q1 2024 706.20K $75.25M Reduce
Q2 2024 76.81K $9.12M Reduce
Q3 2024 26.61K $1.78M Reduce
Q4 2024 1.53M $63.45M Add
Q1 2025 492.26K $13.96M Reduce
Q2 2025 438.68K $12.10M Reduce
Q3 2025 424.69K $10.97M Reduce
Q4 2025 257.17K $7.58M Reduce
Q1 2026 2.20M $111.97M Add
Q2 2026 1.70M $119.21M Reduce
Q3 2026 3.07M $590.92M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 41 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has IMC-Chicago, LLC held MRNA?

IMC-Chicago, LLC has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is IMC-Chicago, LLC's current position in MRNA?

As of Q3 2026, IMC-Chicago, LLC holds 3.07M shares of MRNA (MODERNA INC), valued at $590.92M, representing 0.98% of its reported portfolio and ranking #18.

Has IMC-Chicago, LLC been buying or selling MRNA?

In the latest 13F filing (Q3 2026), IMC-Chicago, LLC increased its position in MRNA. The position peaked in Q3 2026 at 3.07M shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.